{
    "2019-04-05": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Novartis & Amgen in Legal Dispute Over Migraine Drug Aimovig",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Amgen",
                        "Legal Dispute",
                        "Migraine",
                        "Aimovig"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Pharma Stock Roundup: NVS Inks Immunology Deal, PFE, TEVA Get Drug Approvals in EU",
                "features": {
                    "keywords": [
                        "NVS",
                        "Immunology Deal",
                        "PFE",
                        "TEVA",
                        "Drug Approvals",
                        "EU"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "The Zacks Analyst Blog Highlights: Amazon, 3M, Novartis, Schlumberger and ICICI",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Amazon",
                        "3M",
                        "Novartis",
                        "Schlumberger",
                        "ICICI"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "diverse sectors"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Novartis Lawsuit Accuses Amgen Of Trying To Welsh On Migraine Deal",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Lawsuit",
                        "Amgen",
                        "Welsh",
                        "Migraine Deal"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership",
                "features": {
                    "keywords": [
                        "Merrimack",
                        "Early-Stage Trial",
                        "Legal Headache",
                        "Novartis-Amgen",
                        "Migraine Partnership"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}